NCT06964568 2026-02-10
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Fudan University
Phase 3 Recruiting
Clinical Trials
13 trialsNCT04460352 2025-03-06
NEEDS
Karolinska University Hospital
Phase 3 Recruiting
NCT02395705 2022-10-05
Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital
Phase 3 Completed
NCT04138212 2022-08-09
HCHTOG1903
Henan Cancer Hospital
Phase 3 Recruiting
NCT02459457 2022-02-09
A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer
Fudan University
Phase 3 Completed
NCT01126216 2021-05-04
Paccis-RCT
University of Erlangen-Nürnberg Medical School
Phase 3 Terminated
NCT01216111 2020-05-19
Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)
Fudan University
Phase 3 Completed
NCT02891083 2016-09-07
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Shanghai Chest Hospital
Phase 3 Unknown
NCT02461043 2015-09-01
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Adjuvant Chemotherapy in the Treatment of the Lymph Node Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 3 Unknown
NCT00801736 2013-12-10
ET
University College, London
Phase 3 Terminated
NCT01593306 2012-05-08
Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix
Indira Gandhi Medical College, Shimla
Phase 3 Unknown
NCT01405235 2012-04-12
AGO-Zervix-1
Institut fuer Frauengesundheit
Phase 3 Unknown
NCT00779714 2008-10-24
ChemoSensMM
University of Wuerzburg
Phase 3 Unknown